Citation: Pk. Schadlich et Jg. Brecht, THE COST-EFFECTIVENESS OF ACAMPROSATE IN THE TREATMENT OF ALCOHOLISM IN GERMANY - ECONOMIC-EVALUATION OF THE PREVENTION OF RELAPSE WITH ACAMPROSATE IN THE MANAGEMENT OF ALCOHOLISM (PRAMA) STUDY, PharmacoEconomics, 13(6), 1998, pp. 719-730
Citation: Pk. Schadlich et al., ECONOMIC-EVALUATION OF THE CARDIAC-INSUFFICIENCY BISOPROLOL STUDY FORTHE FEDERAL-REPUBLIC-OF-GERMANY, PharmacoEconomics, 13(1), 1998, pp. 147-155
Authors:
BRECHT JG
VOLMER T
SCHADLICH PK
LUTZELBERGER U
Citation: Jg. Brecht et al., COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED COLON-CANCER (CC) OF STAGE DUKES C IN GERMANY - A SUBGROUP ANALYSIS, Annals of oncology, 9, 1998, pp. 179-179
Authors:
LUTZELBERGER U
SCHADLICH PK
VOLMER T
BRECHT JG
Citation: U. Lutzelberger et al., DUKES C COLORECTAL-CARCINOMA - TREATMENT COSTS OF RECURRENCE AFTER CURATIVE RESECTION IN GERMANY, Annals of oncology, 9, 1998, pp. 188-188
Authors:
SCHADLICH PK
LUTZELBERGER U
BRECHT JG
VOLMER T
Citation: Pk. Schadlich et al., MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED DUKES-C COLORECTAL-CARCINOMA (CRC) - A COST-EFFECTIVENESS ANALYSIS IN GERMANY, Annals of oncology, 9, 1998, pp. 198-198
Authors:
SCHADLICH PK
HUPPERTZ E
BRECHT JG
BORCHARDTUCH C
Citation: Pk. Schadlich et al., ECONOMIC-EVALUATION OF RAMIPRIL IN PATIENTS WITH HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION, Perfusion, 10(8), 1997, pp. 266
Citation: Pk. Schadlich et al., BISOPROLOL IN CONGESTIVE-HEART-FAILURE - ECONOMIC-EVALUATION OF THE CARDIAC-INSUFFICIENCY BISOPROLOL STUDY FOR THE FEDERAL-REPUBLIC-OF-GERMANY, Medizinische Klinik, 92(8), 1997, pp. 499-504
Citation: Pk. Schadlich et Jg. Brecht, COST-EFFECTIVENESS ANALYSIS OF THE PROPHY LAXIS OF MYOCARDIAL REINFARCTION WITH LOW-DOSE ACETYLSALICYLIC-ACID - MODEL CALCULATION, Sozial- und Praventivmedizin, 42(2), 1997, pp. 114-120
Authors:
BRECHT JG
JENKE A
KOHLER ME
HARDER S
THURMAN P
RIETBROCK N
Citation: Jg. Brecht et al., RECOMMENDATIONS OF THE GERMAN-SOCIETY-OF- -CONDUCT-AND-EVALUATION-OF-PHARMACOLOGICAL-STUDIES, Medizinische Klinik, 90(9), 1995, pp. 541-546